Enzymatica signs acquisition agreement and prepares for international expansion with new share issue
Enzymatica has signed an agreement to acquire Icelandic company Zymetech via a non-cash issue. This acquisition gives Enzymatica international exclusive rights to a patent-protected enzyme, a key ingredient in ColdZyme® Mouth Spray, as well as control over production of the enzyme, access to international research and development expertise and Zymetech's portfolio. The capital contributed by the subsequent cash issues will enable a stronger focus on commercial investments and international geographic expansion. Enzymatica AB (publ) ("Enzymatica") has signed an agreement to acquire 99.5